New York, February, 25th 2026 — New York Road Runners (NYRR), the nonprofit that “runs” New York City, has named The Myocarditis Foundation an Official Charity Partner of the 2026…
The Myocarditis Foundation was proud to attend the Humble ISD Health & Wellness Community Event on Thursday, February 19th. Events like these give us a valuable opportunity to connect directly…
For decades, myocarditis and inherited cardiomyopathies were viewed as separate heart conditions. Myocarditis was considered an inflammatory disease, usually triggered by infection or autoimmunity, while cardiomyopathies were thought to be…
The Myocarditis Foundation is proud to announce that we have added Jordan Isaacs to our Board of Directors! As a survivor of myocarditis, Jordan has been deeply involved with establishing…
The Myocarditis Foundation is proud to recognize one of our board members Dr. Deipanjan “Deip” Nandi, for being named one of Castle Connolly’s 2026 Top Doctors. This prestigious honor places Dr. Nandi…
The Myocarditis Foundation is pleased to announce a 2026 Research Fellowship Grant being awarded to Dr. Chelsea Phillips. Dr. Phillips completed her PhD in Neuroscience at the University of Michigan…
Immune checkpoint inhibitors have transformed cancer care by helping the immune system better recognize and attack cancer cells. These therapies work by blocking natural “checkpoints” that normally keep immune responses…
Myocarditis is a rare but potentially life-threatening condition caused by inflammation of the heart muscle, most often following a viral infection. In children, myocarditis can be especially difficult to recognize…
The Myocarditis Foundation is pleased to announce a 2025 Research Fellowship Grant being awarded to Dr. Katelyn Bruno, PhD Dr. Katelyn Bruno, of the University of Florida is being awarded…
